UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (Date of earliest event reported):  May 5, 2003

 

COMMISSION FILE NUMBER 333-92383

 

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(Exact Name of Registrant as specified in its Charter)

 

DELAWARE

 

06-1397316

(State of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS 01887

(Address of Principal Executive Offices) (Zip Code)

 

 

 

978-658-6000

(Registrant’s Telephone Number, Including Area Code)

 

 



 

ITEM 9.  REGULATION FD DISCLOSURE

 

On May 5, 2003, Charles River Laboratories, Inc., wholly-owned subsidiary of the Registrant, posted to its company website an updated investor presentation, a copy of which is filed herewith as Exhibit 99.1.

 

 

EXHIBIT 99.1

 

Investor Presentation

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

 

 

Dated: May 5, 2003

 

 

 

 

By:

/s/ Dennis R. Shaughnessy

 

 

 

 

Dennis R. Shaughnessy, Sr. Vice President,

 

Corporate Development, General Counsel

 

and Secretary

 

2